PulseAugur
EN
LIVE 11:20:57

Eating disorders surge 71% as experts warn GLP-1 drugs may worsen the crisis

By PulseAugur Editorial · [1 sources] ·

A recent report indicates a significant increase in eating disorders, with anorexia nervosa and bulimia nervosa incidence rising by 71% between 1990 and 2023. Experts are concerned that popular GLP-1 weight-loss drugs may be exacerbating these conditions, as some individuals with eating disorders are reportedly misusing them. The true prevalence of eating disorders is likely higher than reported, and projections suggest a continued rise in cases. AI

RANK_REASON Article discusses a trend and expert concerns regarding GLP-1 drugs and eating disorders, rather than a specific event.

Read on MIT Technology Review →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Eating disorders surge 71% as experts warn GLP-1 drugs may worsen the crisis

How we ranked this

Signal score
1 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Commentary
Article discusses a trend and expert concerns regarding GLP-1 drugs and eating disorders, rather than a specific event.
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
Breaking (< 6h)
Fresh story with cross-source coverage still developing. Ranking may shift as more sources report.

Full methodology in our editorial standards.

COVERAGE [1]

  1. MIT Technology Review TIER_1 English(EN) · Jessica Hamzelou ·

    Eating disorders are on the rise. GLP-1s could make things worse.

    GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last decade. But to some clinical psychologists, they can represent something more sinister—a potential trigger for eating disorders. A new report suggests that the global incidence of anorexia nervosa an…

RELATED ENTITIES

RELATED TOPICS